Tevogen Bio Holdings Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TVGN research report →
About the company
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID.
- CEO
- Ryan H. Saadi
- IPO
- 2022
- Employees
- 18
- HQ
- Warren, NJ, US
Price Chart
- Market Cap
- $24.35M
- P/E
- -0.99
- P/S
- 0.00
- P/B
- -2.04
- EV/EBITDA
- -1.28
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 241.39%
- ROIC
- 5744.31%
- Revenue
- $0 · 0.00%
- Net Income
- $-26,275,432 · -159.78%
- EPS
- $-8.08 · -72.65%
- Op Income
- $-26,140,515
- FCF YoY
- -3.29%
- 52W High
- $71.00
- 52W Low
- $4.13
- 50D MA
- $8.43
- 200D MA
- $16.80
- Beta
- 0.16
- Avg Volume
- 29.54K
Get TickerSpark's AI analysis on TVGN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 10, 26 | Flomenberg Neal | sell | 19 |
| Mar 11, 26 | Flomenberg Neal | sell | 452 |
| Mar 13, 26 | Flomenberg Neal | sell | 501 |
| Dec 18, 25 | Saadi Ryan H. | other | 50,000 |
| Dec 11, 25 | Desai Kirti | other | 300,000 |
| Dec 11, 25 | Saadi Ryan H. | other | 460,000 |
| Aug 15, 25 | Saadi Ryan H. | other | 20,000 |
| Jun 27, 25 | Saadi Ryan H. | other | 8,000,000 |
| Jun 27, 25 | Khan Sadiq | other | 200,000 |
| Jun 27, 25 | Flomenberg Neal | other | 300,000 |
Our TVGN coverage
Recent articles, reports, and earnings notes.
No research on TVGN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TVGN report →Similar companies
Peers in the same neighborhood.